Bioxyne Limited (BXN.AX)
AUD 0.02
(-9.09%)
AUD 0.02
(-9.09%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 9.32 Million | 5.16 Million | 463.63 Thousand | 2.11 Million | 2.25 Million | 2.2 Million |
| Cost of Revenue | 7.61 Million | 4.81 Million | 687.73 Thousand | 1.47 Million | 1.62 Million | 990.06 Thousand |
| Gross Profit | 1.7 Million | 343.12 Thousand | -224.09 Thousand | 639.7 Thousand | 638.94 Thousand | 1.21 Million |
| Operating Expenses | 3.39 Million | 2.39 Million | 230.34 Thousand | 1.21 Million | 1.21 Million | 2.51 Million |
| Selling, General and Administrative Expenses | 2.98 Million | 2.39 Million | 230.34 Thousand | 897.98 Thousand | 1.08 Million | 2.43 Million |
| Research and Development Expenses | 717.59 Thousand | - | 180.66 Thousand | 89.72 Thousand | 130.24 Thousand | 129.23 Thousand |
| Other Expenses | - | 181.44 Thousand | 88.9 Thousand | -224.42 Thousand | 100.52 Thousand | 165.83 Thousand |
| Cost and Expenses | 10.98 Million | 7.21 Million | 918.07 Thousand | 2.68 Million | 2.83 Million | 3.5 Million |
| Operating Income | -1.65 Million | -2.05 Million | -454.44 Thousand | -572.42 Thousand | -575.98 Thousand | -1.31 Million |
| Interest Expense | - | 582.00 | 582.00 | 1684.00 | 7032.00 | - |
| Income Tax Expense | -310.63 Thousand | -73.99 Thousand | -3.00 | -19.14 Thousand | -48.2 Thousand | -38.9 Thousand |
| Earnings before Tax | -13.28 Million | -2.03 Million | -494.02 Thousand | -514.87 Thousand | -641.3 Thousand | -1.26 Million |
| Net Income | -13.32 Million | -1.93 Million | -494.02 Thousand | -495.72 Thousand | -593.09 Thousand | -1.26 Million |
| Earnings Per Share Basic | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 1.93 Billion | 1.34 Billion | 732.43 Million | 640.14 Million | 640.14 Million | 640.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.93 Billion | 1.34 Billion | 732.43 Million | 640.14 Million | 640.14 Million | 640.14 Million |
| Gross Margin | 0.18 | 0.07 | -0.48 | 0.30 | 0.28 | 0.55 |
| EBIT Margin | -0.18 | -0.38 | -0.91 | -0.23 | -0.17 | -0.59 |
| Profit Margin | -1.43 | -0.38 | -1.07 | -0.23 | -0.26 | -0.57 |
| EBITDA | -1.65 Million | -1.88 Million | -463.29 Thousand | -356.41 Thousand | -440.45 Thousand | -1.28 Million |
| Earnings Before Tax Margin | -0.18 | -0.40 | -0.98 | -0.27 | -0.25 | -0.60 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 9.32 Million | 4.62 Million | 4.7 Million | 5.16 Million | 3.95 Million | 1.2 Million |
| Cost of Revenue | 7.55 Million | 4.01 Million | 3.53 Million | 4.81 Million | 3.38 Million | 738.1 Thousand |
| Gross Profit | 1.77 Million | 607.61 Thousand | 1.16 Million | 343.12 Thousand | 569.06 Thousand | 470.48 Thousand |
| Operating Expenses | 3.47 Million | 846.44 Thousand | 2.2 Million | 2.39 Million | 2.64 Million | 604.26 Thousand |
| Selling, General and Administrative Expenses | - | 785.82 Thousand | 1.85 Million | - | 2.64 Million | 449.33 Thousand |
| Research and Development Expenses | - | 60.61 Thousand | 346.34 Thousand | - | 3274.00 | 6548.00 |
| Other Expenses | - | - | - | 181.44 Thousand | - | -148.38 Thousand |
| Cost and Expenses | 11.02 Million | 4.86 Million | 5.73 Million | 7.21 Million | 6.02 Million | 1.34 Million |
| Operating Income | -1.69 Million | -238.83 Thousand | -1.03 Million | -2.05 Million | -2.07 Million | -133.78 Thousand |
| Interest Expense | 42.04 Thousand | - | - | 582.00 | - | - |
| Income Tax Expense | -310.63 Thousand | 441.08 Thousand | -90.68 Thousand | -73.99 Thousand | 298.85 Thousand | -3274.00 |
| Earnings before Tax | -13.28 Million | -599.3 Thousand | -12.37 Million | -2.03 Million | -1.9 Million | -65.22 Thousand |
| Net Income | -13.32 Million | -1.04 Million | -12.28 Million | -1.93 Million | -1.96 Million | 23.22 Thousand |
| Earnings Per Share Basic | - | -0.00 | -0.01 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | - | -0.00 | -0.01 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 1.93 Billion | 1.93 Billion | 1.9 Billion | 1.34 Billion | 1.32 Billion | 665.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.93 Billion | 1.93 Billion | 1.9 Billion | 1.34 Billion | 1.32 Billion | 665.64 Million |
| Gross Margin | 0.19 | 0.13 | 0.25 | 0.07 | 0.14 | 0.39 |
| EBIT Margin | - | -0.15 | -0.13 | - | -0.44 | -0.66 |
| Profit Margin | -1.43 | -0.23 | -2.61 | -0.38 | -0.50 | 0.02 |
| EBITDA | - | -679.91 Thousand | -613.3 Thousand | - | -1.73 Million | -803.06 Thousand |
| Earnings Before Tax Margin | -0.18 | -0.05 | -0.22 | -0.40 | -0.52 | -0.11 |
OLIV
1354
6645
ARM
WBC
2250